AdAlta Ltd. ( (AU:1AD) ) has provided an announcement.
AdAlta Ltd. has requested a trading halt on the Australian Securities Exchange as it evaluates new financing opportunities. This move is intended to help the company manage its disclosure obligations and maintain an orderly market for its shares, with trading expected to resume by May 2, 2025, or upon the release of a relevant announcement.
More about AdAlta Ltd.
AdAlta Ltd. operates in the biotechnology industry, focusing on developing innovative therapeutic products. The company is known for its work in molecular science, particularly in the development of treatments for fibrotic diseases and cancer.
YTD Price Performance: -50.0%
Average Trading Volume: 589,626
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$3.22M
For a thorough assessment of 1AD stock, go to TipRanks’ Stock Analysis page.